Ypsomed
Benjamin S. is an accomplished manufacturing leader with extensive experience in the medtech and luxury watch industries. Currently serving as the Head of Manufacturing at Ypsomed AG in China since August 2019, Benjamin is instrumental in establishing a new manufacturing plant, overseeing infrastructure, recruitment, and production ramp-up. Previously, at Swatch Group, Benjamin held the position of Head of Production, managing high-precision production processes for luxury watch components. Additional roles include Project Manager and CNC Technician, showcasing expertise in process optimization and precision manufacturing. Benjamin's educational background includes multiple advanced degrees in business administration and engineering, highlighting a strong foundation in production technology and management.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.